News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Regulatory news - May 2017Regulatory news - May 2017Gene-modified T-cells: Going into battleGene-modified T-cells: Going into battleHighlights from ISCT 2017Highlights from ISCT 2017Cynata Therapeutics announce first patient treated in Phase I clinical trialCynata Therapeutics announce first patient treated in Phase I clinical trialStem cell therapies: can anything stop them now?Stem cell therapies: can anything stop them now?ReNeuron awarded major UK cell therapy manufacturing grantReNeuron awarded major UK cell therapy manufacturing grantPress release: Novel cell growth and measurement techniques unveiled at ISCT 2017Press release: Novel cell growth and measurement techniques unveiled at ISCT 2017Regulatory news - April 2017Regulatory news - April 2017Updating our clinical trials and preclinical programmes databasesUpdating our clinical trials and preclinical programmes databasesQuality by design and process automation key for making commercial cell therapiesQuality by design and process automation key for making commercial cell therapiesRegulatory news - March 2017Regulatory news - March 2017Press release: Fisher BioServices’ CryoHub to co-locate with manufacturing centrePress release: Fisher BioServices’ CryoHub to co-locate with manufacturing centre